CIPROFLOXACIN AS THERAPY FOR EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA

被引：78

作者：

NORDEN, CW ^{[1
]}

SHINNERS, E ^{[1
]}

机构：

[1] UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261

来源：

JOURNAL OF INFECTIOUS DISEASES | 1985年 / 151卷 / 02期

关键词：

D O I：

10.1093/infdis/151.2.291

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：291 / 294

页数：4

相关论文

共 6 条

[1] INVITRO ACTIVITY OF CIPROFLOXACIN, A NEW CARBOXYQUINOLINE ANTIMICROBIAL AGENT
ELIOPOULOS, GM
GARDELLA, A
MOELLERING, RC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) : 331 - 335
[2] ACTIVITIES OF TOBRAMYCIN AND AZLOCILLIN ALONE AND IN COMBINATION AGAINST EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA
NORDEN, CW
SHAFFER, MA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) : 62 - 65
[3] EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA
NORDEN, CW
KELETI, E
[J]. JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (01) : 71 - 75
[4] EXPERIMENTAL OSTEOMYELITIS .4. THERAPEUTIC TRIALS WITH RIFAMPIN ALONE AND IN COMBINATION WITH GENTAMICIN, SISOMICIN, AND CEPHALOTHIN
NORDEN, CW
[J]. JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (05) : 493 - 499
[5] NORDEN CW, 1980, BRIT J EXP PATHOL, V61, P451
[6] RESISTANCE TO NALIDIXIC-ACID - MISCONCEPTION DUE TO UNDER-DOSAGE
STAMEY, TA
BRAGONJE, J
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (16): : 1857 - 1860